Cargando…

Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen

BACKGROUND: Caffeine enhances the efficacy of non-opioid analgesics. Data on the cardiovascular health effects of caffeine intake are controversial, and studies on the cardiovascular effects of medical caffeine use are lacking. OBJECTIVE: The study aims to explore the cardiovascular effects of an ib...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampert, Anette, Lange, Robert, Weiser, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173466/
https://www.ncbi.nlm.nih.gov/pubmed/35430997
http://dx.doi.org/10.2174/1574886317666220414125027
_version_ 1785039823895003136
author Lampert, Anette
Lange, Robert
Weiser, Thomas
author_facet Lampert, Anette
Lange, Robert
Weiser, Thomas
author_sort Lampert, Anette
collection PubMed
description BACKGROUND: Caffeine enhances the efficacy of non-opioid analgesics. Data on the cardiovascular health effects of caffeine intake are controversial, and studies on the cardiovascular effects of medical caffeine use are lacking. OBJECTIVE: The study aims to explore the cardiovascular effects of an ibuprofen/caffeine combination in comparison to ibuprofen alone. METHODS: Secondary analysis of a previously reported bioequivalence study of a single dose of a fixed dose ibuprofen/caffeine combination (400/100 mg) vs. ibuprofen alone in a randomized, cross-over design in 36 healthy volunteers. Plasma catecholamines were analyzed to enhance mechanistic interpretation of the data. RESULTS: After exclusion of 10 protocol violators (pre-dosing intake of caffeine), vital signs were comparable over a 24-h period in the absence and presence of caffeine. Plasma catecholamine levels were also comparable. CONCLUSION: These data do not support the hypothesis that occasional intake of a small dose of caffeine as part of pain medication imposes a health risk due to vital sign changes. Based on the proven increase in efficacy, the addition of caffeine to non-opioid analgesics such as IBU has a favorable risk/benefit profile for occasional use.
format Online
Article
Text
id pubmed-10173466
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-101734662023-05-12 Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen Lampert, Anette Lange, Robert Weiser, Thomas Curr Drug Saf Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology BACKGROUND: Caffeine enhances the efficacy of non-opioid analgesics. Data on the cardiovascular health effects of caffeine intake are controversial, and studies on the cardiovascular effects of medical caffeine use are lacking. OBJECTIVE: The study aims to explore the cardiovascular effects of an ibuprofen/caffeine combination in comparison to ibuprofen alone. METHODS: Secondary analysis of a previously reported bioequivalence study of a single dose of a fixed dose ibuprofen/caffeine combination (400/100 mg) vs. ibuprofen alone in a randomized, cross-over design in 36 healthy volunteers. Plasma catecholamines were analyzed to enhance mechanistic interpretation of the data. RESULTS: After exclusion of 10 protocol violators (pre-dosing intake of caffeine), vital signs were comparable over a 24-h period in the absence and presence of caffeine. Plasma catecholamine levels were also comparable. CONCLUSION: These data do not support the hypothesis that occasional intake of a small dose of caffeine as part of pain medication imposes a health risk due to vital sign changes. Based on the proven increase in efficacy, the addition of caffeine to non-opioid analgesics such as IBU has a favorable risk/benefit profile for occasional use. Bentham Science Publishers 2023-01-01 2023-01-01 /pmc/articles/PMC10173466/ /pubmed/35430997 http://dx.doi.org/10.2174/1574886317666220414125027 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
spellingShingle Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology
Lampert, Anette
Lange, Robert
Weiser, Thomas
Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
title Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
title_full Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
title_fullStr Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
title_full_unstemmed Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
title_short Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
title_sort lack of evidence for blood pressure effects of caffeine added to ibuprofen
topic Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173466/
https://www.ncbi.nlm.nih.gov/pubmed/35430997
http://dx.doi.org/10.2174/1574886317666220414125027
work_keys_str_mv AT lampertanette lackofevidenceforbloodpressureeffectsofcaffeineaddedtoibuprofen
AT langerobert lackofevidenceforbloodpressureeffectsofcaffeineaddedtoibuprofen
AT weiserthomas lackofevidenceforbloodpressureeffectsofcaffeineaddedtoibuprofen